Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB08930> ?p ?o ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- drugbank:DB08930 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08930 label "Dolutegravir [drugbank:DB08930]" assertion.
- drugbank:DB08930 seeAlso DB08930 assertion.
- drugbank:DB08930 seeAlso dolutegravir.html assertion.
- drugbank:DB08930 identifier "drugbank:DB08930" assertion.
- drugbank:DB08930 description "Dolutegravir is indicated for HIV-1 infection for adults and children and adolescents ≥12 years of age and weighing ≥40 kg. It is marketed as Tivicay as dolutegravir sodium. 52.6 mg of dolutegravir sodium is equivalent to 50 mg dolutegravir free acid. FDA approved on August 12, 2013." assertion.
- drugbank:DB08930 title "Dolutegravir" assertion.
- drugbank:DB08930 bio2rdf_vocabulary:identifier "DB08930" assertion.
- drugbank:DB08930 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08930 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08930" assertion.
- drugbank:DB08930 bio2rdf_vocabulary:x-identifiers.org DB08930 assertion.
- drugbank:DB08930 drugbank_vocabulary:drugbank-id "DB08930" assertion.
- drugbank:DB08930 drugbank_vocabulary:x-cas cas:1051375-16-6 assertion.
- drugbank:DB08930 drugbank_vocabulary:x-ahfs ahfs:8:18.08.12 assertion.
- drugbank:DB08930 drugbank_vocabulary:x-chebi chebi:76014 assertion.
- drugbank:DB08930 drugbank_vocabulary:x-kegg kegg:D10066 assertion.
- drugbank:DB08930 drugbank_vocabulary:x-wikipedia wikipedia:Dolutegravir assertion.
- drugbank:DB08930 drugbank_vocabulary:x-ndc ndc:49702-228-13 assertion.